Bayno, Alemae T.
HRN: 22-97-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
CEFUROXIME 500MG (TAB)
06/30/2023
07/07/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes